摘要
目的 研究大鼠口服西红花的主要活性成分西红花苷-1后，药物的吸收入血成分及药动学。方法 大鼠口服西红花苷-1后的血浆经过含酸丙酮或丙酮沉淀，采用Agilent Zorbax SB-C18柱，在420 nm检测波长下，分别分析经葡萄糖醛酸酶水解前后血浆中的西红花苷-1（流动相为：甲醇-0.5%醋酸=48∶52）与西红花酸（流动相为：甲醇-0.5%醋酸=74∶36）。结果 在大鼠口服西红花苷-1后不同时间点的血浆以及葡萄糖醛酸酶水解后血浆中未检出西红花苷-1成分，但是在血浆中检测到较高浓度的西红花酸，葡萄糖醛酸水解后的血浆中西红花酸含量未见明显增加。对大鼠口服1 mg·kg-1西红花苷-1后24 h内的血浆样品中的西红花酸进行血药浓度分析，结果显示，西红花酸在6只大鼠的血浆中都显示多次达峰现象，10 h之内维持较稳定的血药浓度。平均血药浓度显示第一达峰时间（tmax1）在20 min，峰浓度为（0.17±0.18 ）μg·mL-1，第二达峰时间（tmax2）在6 h，峰浓度为（0.14±0.07）μg·mL-1，平均滞留时间（MRT0-t）为（5.4±0.7） h，末端消除半衰期（t1/2k）为（3.0±0.6） h。结论 西红花苷-1口服给药后以代谢物西红花酸形式快速吸收入血，消除半衰期和体内滞留时间较长，具有良好的药动学特征。对于西红花苷-1在体活性的研究需要重视对体内吸收成分——西红花酸的药理作用的探讨。
Abstract
OBJECTIVE To elucidate the intestinal absorption and pharmacokinetic characteristics of crocin-1， a major active constituent of the stigmas of saffron (Crocus sativus L) in rats after oral administration. METHODS Extracted plasma samples were eluted by the mobile phase composed of methanol-2%acetate acid (pH 2) (48∶52 for crocin-1 and 74∶36 for crocetin) on Agilent Zorbax SB-C18 column monitored at 420 nm. RESULTS An accurate， precise and selective analysis method was developed to determine crocein in rat plasma with the quantitation limit of 10 ng·mL-1. No crocin-1 was detected in both original and β-glucuronidase treated plasma samples. However， appreciable crocetin， the aglycon form of crocin-1， was observed in the original plasma. The concentration of crocetin did not increase obviously after hydrolization by β-glucuronidase. The average concentration-time data after oral administration of 1 mg·kg-1 crocin-1 showed that crocin-1 was rapidly absorbed as crocein and remained above 50 ng·mL-1 for about 10 h. The first peak appeared at 20 min and the second peak at 6 h. The area under curve (AUC)， mean residence time (MRT) during 0-24 h and elimination half-life (t1/2k) were calculated as （1.16±0.22） μg·h·mL-1， （5.4±0.7） and （3.0±0.6） h， respectively. CONCLUSION Crocin-1 is absorbed as its hydrolyzation metabolite and shows relatively good pharmacokinetic characteristics. Crocetin may be thereby related to the pharmacological activities of crocin-1 in vivo.
关键词
西红花苷-1 /
西红花酸 /
代谢物 /
吸收 /
药动学
{{custom_keyword}} /
Key words
crocin-1 /
crocetin /
metabolite /
absorption /
pharmacokinetics
{{custom_keyword}} /
张颖 刘建勋 林力 李利群.
大鼠口服西红花苷-1后吸收入血成分及药动学[J]. 中国药学杂志, 2012, 47(2): 136-140
Pharmacokinetics of Crocin-1 After Oral Administration in Rats[J]. Chinese Pharmaceutical Journal, 2012, 47(2): 136-140
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] LI N， LIN G， KWAN Y W， et al. Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography[J]. Chromatogr A， 1999， 849(2)：349-355.
[2] XU G L， QIAN Z Y. Protective effect of crocin-1 on bovine aortic endothelial cells[J]. Chin Tradit Herb Drugs(中草药)， 2002， 33(5)： 439-442.
[3] ZHANG Y X， SUGIURA M， SAITO H， et al. Acute effects of Crocus sativus L. on passive avoidance performance in mice[J]. Biol Pharmacol Bull， 1994， 17(2)： 217-221.
[4] ABE K， SUGIURA M， YAMAGUCHI S， et al. Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivo[J]. Brain Res， 1999， 851(1-2)：287-289.
[5] XUAN B， ZHOU Y H， LI N， et al. Effects of crocin analogues on ocular blood flow and retinal function[J]. J Ocul Pharmacol Ther， 1999， 15(2)： 143-152.
[6] HOSSEINZADEH H， KHOSRAVAN V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice[J]. Arch Irn Med， 2002， 5(1)： 44-47.
[7] HOSSEINZADEH H， KARIMI G H， NIAPOOR M. Antidepressant effects of Crocus sativus stigma extracts and its constituents， crocin and safranal， in mice[J]. Acta Hort， 2004， 650： 435-445.
[8] HOSSEINZADEH H， YOUNESI H M. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice[J]. BMC Pharmacol， 2002， 2(1)： 1-8.
[9] ABDULLAEV F J. Biological effects of saffron[J]. Biofactors， 1993， 4(1)： 83-86.
[10] ESCRIBANO J， ALONSO G L， COCA-PRADOS M， et al. Crocin， safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro[J]. Cancer Lett， 1996， 100(1)： 23-30.
[11] LI X Y， FENG W L， YUAN M. Determination of crocin in rat plasma and pharmacokinetics study by HPLC[J]. J Qinghai Medi Coll(青海医学院学报)， 2007， 28(2)： 73-78.
[12] QIAN Z Y， FU J， PAN Y.The pharmacokinetics of crocin-1 in rats [J]. J China Pharm Univ (中国药科大学学报)， 1996， 27(12)： 755-757.
[13] DU P， QIAN Z Y. Studies on the absorption and excretion of crocin-1 in rats [J]. Chin J New Drugs(中国新药杂志)， 2004， 13(9)：802-804.
[14] ASAI A， NAKANO T， TAKAHASHI M， et al. Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice [J]. J Agric Food Chem， 2005， 53(18)： 7302-7306.
[15] JIN Y Y， ZHANG J T， ZHANG Y， et al. Studies on the intestinal absorption of crocin in rats and determination of the partition coefficient[J]. J China Pharm Univ (中国药科大学学报)， 2004， 35(9)： 283-284.
[16] SATOH T， HOSAKAWA M. Structure， function and regulation of carboxylesterases[J]. Chem Biol Interact， 2006， 162(3)： 195-211.
[17] DU P， QIAN Z Y， YU W P， et al. Study on pharmacokinetics and tissue distribution of crocetin in rats by RP-HPLC[J]. Chin J Pharm Anal(药物分析杂志)， 2004， 24(2)：149-153.
[18] GAO C， PENG F C， QIAN Z Y. Protective effects of crocetin on cerebral ischemia-reperfusion injury in mice[J]. Chin J Clin Pharmacol Ther (中国临床药理学与治疗学)， 2009， 14(4)：421-425.
[19] ZHAO B H， QIAN Z Y， CHEN Z， et al. Hypocholesterolemic effect of crocetin on serum cholesterol in rats and the mechanism[J]. Chin J New Drugs(中国新药杂志)， 2009，18(14)：1347-1351.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金重点项目（30830118）；科技部科技重大专项（2009ZX09102-137，2009ZX09102-137）课题资助
{{custom_fund}}
PDF(1092 KB)
